Impact of (18)F-FDG PET/CT imaging in therapeutic decisions for malignant solitary fibrous tumor of the pelvis.
Clin Nucl Med
; 38(6): 453-5, 2013 Jun.
Article
in En
| MEDLINE
| ID: mdl-23486317
ABSTRACT
The decision to give neoadjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma is often based on tumor grade evaluated from biopsies, but biopsies can have the inherent issue of sampling bias. Incorporation of SUVmax and heterogeneity assessed by F-FDG PET/CT could be other crucial components in the effort to tailor treatment to an individual patient, providing valuable parameters to guide the selection of the most appropriate management schedule for an individual. We present 1 representative case describing how FDG PET/CT can assist in clinical management decisions for treatment of malignant solitary fibrous tumor of the pelvis.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pelvic Neoplasms
/
Pelvis
/
Fluorodeoxyglucose F18
/
Solitary Fibrous Tumors
/
Multimodal Imaging
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Nucl Med
Year:
2013
Document type:
Article
Affiliation country:
United States